RCKT Q4 2022 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RCKTRocket Pharmaceuticals, Inc.

$572M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$69M

Net Income

-$67M

EPS (Diluted)

$-0.88

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$59M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$552M

Total Liabilities

$62M

Stockholders' Equity

$490M

Cash & Equivalents

$141M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$69M	-$44M	-55.8%
Net Income	-$67M	-$44M	-50.8%